Delcath director granted 22,500 stock options
DELCATH SYSTEMS, INC. director Steven A. J. Salamon received a grant of stock options covering 22,500 shares of common stock.
Rhea-AI Filing Summary
DELCATH SYSTEMS, INC. director Steven A. J. Salamon received a grant of stock options covering 22,500 shares of common stock. The options have an exercise price of $11.61 per share and represent a compensation-related award, not an open-market purchase.
The options vest in equal monthly installments of one-twelfth of the grant, starting on May 13, 2026, as long as he continues serving as a director under the company’s 2020 Omnibus Equity Incentive Plan. The options expire 10 years from the grant date or, for vested portions, two years after his last day of service.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 22,500 shares
Grant/Award
1 txn
Insider
SALAMON STEVEN A J
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 22,500 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 22,500 contracts (Direct)
Footnotes (1)
- F1. The option will vest and become exercisable at the rate of one-twelfth (1/12th) per month with the first such vesting to occur on May 13, 2026 and monthly thereafter for so long as the reporting person remains a director of the Issuer (and subject to the terms and conditions of the Issuer's 2020 Omnibus Equity Incentive Plan, as amended). The option will expire the earlier of 10 years from the grant date or, for vested options, two years from the last day of service.
Key Figures
Options granted: 22,500 options
Exercise price: $11.61 per share
Underlying shares: 22,500 shares
+5 more
8 metrics
Options granted
22,500 options
Stock Option (right to buy) grant to director
Exercise price
$11.61 per share
Exercise price for the stock options
Underlying shares
22,500 shares
Common stock underlying the option grant
Post-transaction options held
22,500 options
Total options reported following this grant
Vesting start date
May 13, 2026
First monthly vesting date for the options
Vesting rate
1/12 per month
Monthly vesting schedule while serving as director
Maximum option term
10 years
Outside limit from grant date before expiration
Post-service exercise window
2 years
For vested options after last day of service
Key Terms
Stock Option (right to buy), vesting, 2020 Omnibus Equity Incentive Plan, exercise price
4 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
vesting financial
"The option will vest and become exercisable at the rate of one-twelfth"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
2020 Omnibus Equity Incentive Plan financial
"subject to the terms and conditions of the Issuer's 2020 Omnibus Equity Incentive Plan"
exercise price financial
"conversion_or_exercise_price: 11.6100"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did DELCATH SYSTEMS (DCTH) report on this Form 4?
DELCATH SYSTEMS reported a director receiving 22,500 stock options as a compensation grant. These options give the right to buy common shares at a fixed price and do not involve any open-market buying or selling of existing stock.
How many DELCATH SYSTEMS (DCTH) options were granted to the director?
The director was granted stock options on 22,500 underlying shares of DELCATH common stock. This entire amount is a new award and represents his total option holdings reported following this transaction in the Form 4 data.
What is the exercise price of the new DELCATH SYSTEMS (DCTH) stock options?
The granted stock options have an exercise price of $11.61 per share. This means the director can purchase DELCATH common stock at $11.61 once the options vest, regardless of the future market price.
When do the DELCATH SYSTEMS (DCTH) options granted to the director vest?
The options vest in monthly installments of one-twelfth of the grant, beginning May 13, 2026. Vesting continues each month as long as the individual remains a director and is subject to the company’s 2020 Omnibus Equity Incentive Plan.
What is the expiration policy for the new DELCATH SYSTEMS (DCTH) stock options?
The options expire the earlier of 10 years from the grant date or, for vested options, two years after the director’s last day of service. After expiration, any unexercised options can no longer be used to purchase shares.
Is the DELCATH SYSTEMS (DCTH) Form 4 transaction a market purchase or sale?
The Form 4 shows a grant of stock options as compensation, not a market trade. The director did not buy or sell shares on the open market; he received options that may be exercised in the future after vesting.
AI-generated analysis. How Rhea-AI works. Not financial advice.
